ABERRANT P53 EXPRESSION IS THE STRONGEST PREDICTOR FOR NEOPLASTIC PROGRESSION IN PATIENTS WITH BARRETT’S ESOPHAGUS

Pauline Zellenrath  1     Judith Honing  1     Pieter Jan de Jonge  1     Arjun D. Koch  1     Manon C.W. Spaander  1    
1 Erasmus University Medical Center, Rotterdam, Netherlands

Topic
Oesophagus

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing